Literature DB >> 17970885

Update on the dermatologic use of systemic glucocorticosteroids.

Scott Jackson1, Heidi Gilchrist, Lee T Nesbitt.   

Abstract

Systemic glucocorticosteroids (GCS) remain a first-line therapy for a variety of dermatologic diseases. The purpose of this article is to review the major pharmacologic properties and drug interactions of GCS, as well as the mechanisms of action, dosing and delivery options, and major adverse effects. In addition, the present authors will discuss the major indications and practical suggestions for the use of systemic GCS in dermatology.

Mesh：

Substances：

Year:  2007        PMID： 17970885     DOI： 10.1111/j.1529-8019.2007.00133.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   2.851


  8 in total

Review 1.  [Principles of glucocorticoid therapy].

Authors:  J Ehrchen
Journal:  Hautarzt       Date:  2012-12       Impact factor: 0.751

2.  Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis.

Authors:  Marianne Demerjian; Eung-Ho Choi; Mao-Qiang Man; Sandra Chang; Peter M Elias; Kenneth R Feingold
Journal:  Exp Dermatol       Date:  2009-02-19       Impact factor: 3.960

3.  Cutaneous glucocorticosteroidogenesis: securing local homeostasis and the skin integrity.

Authors:  Andrzej T Slominski; Pulak R Manna; Robert C Tuckey
Journal:  Exp Dermatol       Date:  2014-06       Impact factor: 3.960

4.  Gene expression in Atlantic salmon skin in response to infection with the parasitic copepod Lepeophtheirus salmonis, cortisol implant, and their combination.

Authors:  Aleksei Krasnov; Stanko Skugor; Marijana Todorcevic; Kevin A Glover; Frank Nilsen
Journal:  BMC Genomics       Date:  2012-04-05       Impact factor: 3.969

5.  Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2.

Authors:  Nicola Cirillo; David J Morgan; Maria Carmela Pedicillo; Antonio Celentano; Lorenzo Lo Muzio; Michael J McCullough; Stephen S Prime
Journal:  Br J Cancer       Date:  2017-08-10       Impact factor: 7.640

6.  Urinary Proteomics Analysis of Active Vitiligo Patients: Biomarkers for Steroid Treatment Efficacy Prediction and Monitoring.

Authors:  Yue-Tong Qian; Xiao-Yan Liu; Hai-Dan Sun; Ji-Yu Xu; Jia-Meng Sun; Wei Liu; Tian Chen; Jia-Wei Liu; Yan Tan; Wei Sun; Dong-Lai Ma
Journal:  Front Mol Biosci       Date:  2022-02-17

Review 7.  Gestational pemphigoid.

Authors:  Laura Huilaja; Kaarin Mäkikallio; Kaisa Tasanen
Journal:  Orphanet J Rare Dis       Date:  2014-09-02       Impact factor: 4.123

Review 8.  Diagnosis and Treatment of Keloids and Hypertrophic Scars-Japan Scar Workshop Consensus Document 2018.

Authors:  Rei Ogawa; Sadanori Akita; Satoshi Akaishi; Noriko Aramaki-Hattori; Teruyuki Dohi; Toshihiko Hayashi; Kazuo Kishi; Taro Kono; Hajime Matsumura; Gan Muneuchi; Naoki Murao; Munetomo Nagao; Keisuke Okabe; Fumiaki Shimizu; Mamiko Tosa; Yasuyoshi Tosa; Satoko Yamawaki; Shinichi Ansai; Norihisa Inazu; Toshiko Kamo; Reiko Kazki; Shigehiko Kuribayashi
Journal:  Burns Trauma       Date:  2019-12-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.